Draper Asset Management, LLC Crispr Therapeutics Ag Call Options Transaction History

Draper Asset Management, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 12, 2024	BUY	$38.62 - $72.18 $38,620 - $72,180	1,000 Added 58.82%	2,700 $169,000
Q1 2023 May 05, 2023	SELL	$41.0 - $56.12 $24,600 - $33,672	-600 Reduced 26.09%	1,700 $76,000
Q4 2022 Feb 08, 2023	BUY	$39.19 - $65.67 $90,137 - $151,041	2,300 New	2,300 $93,000
Q2 2022 Aug 12, 2022	BUY	$43.23 - $73.83 $86,460 - $147,660	2,000 Added 666.67%	2,300 $31,000
Q4 2021 Feb 14, 2022	BUY	$70.09 - $111.29 $21,027 - $33,387	300 New	300 $3,000

491

58M

1.1M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.74B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Draper Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Draper Asset Management, LLC with notifications on news.